News

The microbiome is the latest research frontier in obesity and the latest studies – and future speculation – were under discussion at the recent American Diabetes Association’s 83rd Sci...

Increasing the knowledge of all healthcare professionals involved with diabetes can improve glycaemic outcomes and care transitions. A Diabetes Champion programme was discussed at the American Diabetes Assoc...

Suzie Normanton, Feedback Lead in the EASD e-Learning team, reports on the range of external feedback received by the platform during the first six months of 2023 – and highlights how this fe...

Two weekly insulins are well into clinical development, with trials showing promising results so far. An expert panel at the American Diabetes Association’s 83rd Scientific Sessions discussed how ...

There are more people on the move around the world than ever before, so it is crucial to understand the specific factors that affect immigrants’ health. An expert panel discussed the latest resear...

In the latest EASD e-Learning module, leading experts in diabetes care and research guide learners through the latest ADA/EASD consensus report on managing type 2 diabetes.

The findings of the SURMOUNT-2 trial were unveiled in a panel discussion at the American Diabetes Association 83rd Scientific Sessions recently. The study showed that weekly tirzepatide leads to signifi...

Optimal medical therapy, as recommended in clinical guidelines, is underused in high-risk patients with type 2 diabetes and cardiovascular disease, heart failure and chronic kidney disease. The COORDINATE-Di...

The impact on calorie intake of portion size, energy density and plant-based and ultra-processed foods was discussed at the American Diabetes Association’s 83rd Scientific Sessions held in San Die...

Five modules on EASD’s e-Learning platform have been accredited for continuing professional development (CPD) by the Royal College of General Practitioners (RCGP). 

Chronic kidney disease (CKD) and heart failure in type 2 diabetes were under discussion at the recent Primary Care Diabetes Europe conference. Screening and implementing the latest research need to be priori...

David Matthews, Professor Emeritus in Diabetic Medicine at the University of Oxford, gave the Paul Cromme Award Lecture at the recent Primary Care Diabetes Europe (PCDE) conference in Barcelona. Professor Ma...

The EASD’s entire e-Learning platform has been accredited for continuing professional development (CPD) by the UK’s Federation of the Royal Colleges of Physicians (RCP). 

Type 2 diabetes is increasingly being diagnosed among people under the age of 40. Early-onset diabetes is associated with an increased risk of complications and requires more intensive intervention, accordin...

Another 15 modules on the EASD e-Learning platform have now been accredited for continuing professional development (CPD) by the Federation of the Royal Colleges of Physicians of the UK (RCP), taking the num...

Immunotherapy offers new hope to those at risk of type 1 diabetes, with teplizumab being the first approved treatment. Research into identifying those most likely to respond to immunotherapy and which treatm...

As we come out the other side of the COVID-19 pandemic, a webinar hosted by the International Diabetes Federation (IDF) focused on the challenges and lessons learned in different parts of the world. Lisa Buc...

The COVID-19 pandemic forced diabetes clinics to go online at short notice. The benefits and challenges involved in the continuing use of telemedicine in diabetes care were in the spotlight at the recent Adv...

People at risk of type 1 diabetes can be identified before symptoms occur, reducing the risk of an emergency diagnosis. Initiatives around the world looking at population-based screening for the condition we...

In EASD e-Learning’s latest module, which launches today, Professor Eelco de Koning examines the different patient journeys for islet transplantation that are available to people with diabetes, accordi...

Many factors, including ethnicity, location and socioeconomic status, contribute to disparities in diabetes care and it is important that these are addressed to improve clinical outcomes and quality of life ...